We’re proud to share Icon Group’s 2023 Annual Research Report which includes a feature on the relaunch of Icon Cancer Foundation.
The report showcases the work of Icon’s global research team and the impact they are making in advancing cancer care. ICF are proud to sponsor Icon’s Investigator Initiated Trials (IITs) which at Icon focus on new and emerging treatments particularly within the field of radiation medicine and rely on community funding.
Take a look at the full report: https://lnkd.in/gDzc68Jg